RSLSReShape Lifesciences Inc.

Nasdaq reshapelifesciences.com


$ 0.18 $ 0.01 (4.97 %)    

Thursday, 02-May-2024 15:59:25 EDT
QQQ $ 429.07 $ 5.38 (1.28 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 505.01 $ 4.68 (0.94 %)
TLT $ 88.87 $ 0.38 (0.43 %)
GLD $ 213.12 $ -0.66 (-0.31 %)
$ 0.1753
$ 0.17
$ 0.00 x 0
$ 0.00 x 0
$ 0.17 - $ 0.18
$ 0.14 - $ 2.80
231,086
na
1.04M
$ 1.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-01-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-07-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 04-17-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-19-2022 06-30-2022 10-Q
8 05-23-2022 03-31-2022 10-Q
9 04-08-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-12-2021 03-31-2021 10-Q
13 03-12-2021 12-31-2020 10-K
14 11-06-2020 09-30-2020 10-Q
15 07-30-2020 06-30-2020 10-Q
16 06-19-2020 03-31-2020 10-Q
17 02-27-2020 12-31-2019 10-K
18 11-08-2019 09-30-2019 10-Q
19 07-24-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 02-22-2019 12-31-2018 10-K
22 11-02-2018 09-30-2018 10-Q
23 08-02-2018 06-30-2018 10-Q
24 05-10-2018 03-31-2018 10-Q
25 03-05-2018 12-31-2017 10-K
26 11-03-2017 09-30-2017 10-Q
27 08-02-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 02-23-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reshape-lifesciences-tweets-will-glp1-medications-replace-weightloss-surgery-according-to-reshape-ceo-paul-hickey-via-investingcom-glp1s-are-a-very-attractive-tool-to-fight-obesity-however-our-reshape-lap-band-is-safe-and-less-invasive

https://twitter.com/ReShapeLifesci/status/1775577028710015364

 reshape-lifesciences-fy23-sales-8678m-miss-8904m-estimate

Reshape Lifesciences (NASDAQ:RSLS) reported quarterly sales of $8.678 million which missed the analyst consensus estimate of $8...

 reshape-lifesciences-announces-first-surgeries-utilizing-next-generation-lap-band-20-flex

FLEX Technology Designed to Enhance the Patient Experience Surgeon Training Underway for the Initial Launch of the Lap-Band® 2....

 reshape-lifesciences-posts-on-x-there-is-growing-consumer-awareness-of-medical-weightloss-generated-by-glp-1s-reshape-lifesciences-is-tapping-into-this-market-with-our-full-portfolio-of-weight-loss-and-wellness-solutions

https://twitter.com/ReShapeLifesci/status/1759986276994809885?s=20 

 reshape-lifesciences-us-patent-application-20240016635-published-today-for-intragastric-device-for-treating-obesity

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240016635

 dow-jumps-over-200-points-federal-reserve-holds-interest-rates-steady

U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision on Wednesday. The...

 why-despegarcom-shares-are-trading-higher-by-over-16-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial ...

 crude-oil-gains-15-blackboxstocks-shares-plummet

U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 3...

 why-reshape-lifesciences-stock-is-ripping-higher

ReShape Lifesciences, Inc. (NASDAQ: RSLS) shares are trading higher Wednesday after the company announced it has received FDA P...

 us-stocks-mixed-producer-prices-unchanged-for-november

U.S. stocks traded mixed this morning, following the release of PPI data on Wednesday. Following the market opening Wednesday,...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION